Unveiling COVID-19-associated organ-specific cell types and cell-specific pathway cascade

被引:13
|
作者
Dey, Ashmita [1 ]
Sen, Sagnik [1 ]
Maulik, Ujjwal [1 ]
机构
[1] Jadavpur Univ, Dept Comp Sci & Engn, Kolkata 32, W Bengal, India
关键词
D O I
10.1093/bib/bbaa214
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The novel coronavirus or COVID-19 has first been found in Wuhan, China, and became pandemic. Angiotensin-converting enzyme 2 (ACE2) plays a key role in the host cells as a receptor of Spike-I Glycoprotein of COVID-19 which causes final infection. ACE2 is highly expressed in the bladder, ileum, kidney and liver, comparing with ACE2 expression in the lung-specific pulmonary alveolar type II cells. In this study, the single-cell RNAseq data of the five tissues from different humans are curated and cell types with high expressions of ACE2 are identified. Subsequently, the protein-protein interaction networks have been established. From the network, potential biomarkers which can form functional hubs, are selected based on k-means network clustering. It is observed that angiotensin PPAR family proteins show important roles in the functional hubs. To understand the functions of the potential markers, corresponding pathways have been researched thoroughly through the pathway semantic networks. Subsequently, the pathways have been ranked according to their influence and dependency in the network using PageRank algorithm. The outcomes show some important facts in terms of infection. Firstly, renin-angiotensin system and PPAR signaling pathway can play a vital role for enhancing the infection after its intrusion through ACE2. Next, pathway networks consist of few basic metabolic and influential pathways, e.g. insulin resistance. This information corroborate the fact that diabetic patients are more vulnerable to COVID-19 infection. Interestingly, the key regulators of the aforementioned pathways are angiontensin and PPAR family proteins. Hence, angiotensin and PPAR family proteins can be considered as possible therapeutic targets.
引用
收藏
页码:914 / 923
页数:10
相关论文
共 50 条
  • [21] β-Cyclodextrin-based geometrically frustrated amphiphiles as one-component, cell-specific and organ-specific nucleic acid delivery systems
    Rivero-Barbarroja, Gonzalo
    Lopez-Fernandez, Jose
    Juarez-Gonzalvez, Inmaculada
    Fernandez-Clavero, Carlos
    Di Giorgio, Christophe
    Velaz, Itziar
    Garrido, Maria J.
    Benito, Juan M.
    Mellet, Carmen Ortiz
    Mendicuti, Francisco
    de Ilarduya, Conchita Tros
    Fernandez, Jose M. Garcia
    CARBOHYDRATE POLYMERS, 2025, 347
  • [22] Defining the transcriptional basis of organ-specific endothelial cell specialization
    Nature Cardiovascular Research, 2025, 4 (4): : 360 - 361
  • [23] Metabolic programming of organ-specific natural killer cell responses
    Delconte, Rebecca B.
    Sun, Joseph C.
    IMMUNOLOGICAL REVIEWS, 2024, 323 (01) : 8 - 18
  • [25] Systemic and organ-specific immune-related manifestations of COVID-19
    Manuel Ramos-Casals
    Pilar Brito-Zerón
    Xavier Mariette
    Nature Reviews Rheumatology, 2021, 17 : 315 - 332
  • [26] Systemic and organ-specific immune-related manifestations of COVID-19
    Ramos-Casals, Manuel
    Brito-Zeron, Pilar
    Mariette, Xavier
    NATURE REVIEWS RHEUMATOLOGY, 2021, 17 (06) : 315 - 332
  • [27] Reply to Savolainen: Organ- and Cell-specific GAG Chains
    Zaia, Joseph
    Shi, Xiaofeng
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (18)
  • [28] Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus
    Walter, Korden
    Bonifer, Constanze
    Tagoh, Hiromi
    BLOOD, 2008, 112 (05) : 1673 - 1682
  • [29] Defining COVID-19-associated hyperinflammatory syndrome in specific populations Comment
    Webb, J. Brandon
    LANCET RHEUMATOLOGY, 2021, 3 (09): : E609 - E611
  • [30] Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning
    Maitray A. Patel
    Michael J. Knauer
    Michael Nicholson
    Mark Daley
    Logan R. Van Nynatten
    Gediminas Cepinskas
    Douglas D. Fraser
    Molecular Medicine, 29